Keeping in line with its commitment to educating not only the public, but clinicians as well, Valley Hospital held its second annual Neurocritical Care Symposium on January 25. In what will likely become a recurring event, the symposium featured distinguished presenters, who spoke to the more than 120 health care providers in attendance on topics such as stroke management and traumatic spinal cord injury. The Gamma Knife Center’s co-director, Neurosurgeon Anthony D’Ambrosio, M.D., discussed the management of malignant and benign brain tumors.
“Attendees were curious about the role of Gamma Knife radiosurgery in the treatment of patients with brain tumors,” Dr. D’Ambrosio says, further pointing out the critical need for keeping those in the health care field up to date on the latest treatment options available to neuro patients. ”I reviewed the integral role Gamma Knife plays in both the surgical and non-surgical treatment paradigms I use in patients with brain metastases, vestibular schwannomas and meningiomas. People were excited to hear that Gamma Knife radiosurgery can be utilized as the sole, up-front treatment for many tumors of the brain, or as a postoperative adjunct for residual or recurrent tumors. I also presented our own data supporting the finding that Gamma Knife radiosurgery, when used in selected patients with metastatic tumors to the brain, often results in significantly longer survival times.”
The symposium was free and offered continuing medical credits for nursing and medical staff.
